BIONDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 46.213
EU - Europa 19.490
AS - Asia 10.916
SA - Sud America 620
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 52
OC - Oceania 37
Totale 77.424
Nazione #
US - Stati Uniti d'America 45.520
IT - Italia 4.688
SG - Singapore 4.373
CN - Cina 3.092
SE - Svezia 2.745
IE - Irlanda 2.701
DE - Germania 2.649
RU - Federazione Russa 1.915
HK - Hong Kong 1.836
UA - Ucraina 1.646
GB - Regno Unito 949
CA - Canada 645
FI - Finlandia 529
BR - Brasile 519
VN - Vietnam 384
ID - Indonesia 381
FR - Francia 366
AT - Austria 351
TR - Turchia 257
IN - India 238
NL - Olanda 228
DK - Danimarca 198
BE - Belgio 156
JP - Giappone 69
IR - Iran 51
CH - Svizzera 49
ES - Italia 42
PL - Polonia 40
EU - Europa 38
CZ - Repubblica Ceca 37
RO - Romania 35
BG - Bulgaria 33
AU - Australia 31
PK - Pakistan 29
AR - Argentina 24
GR - Grecia 24
EG - Egitto 22
KR - Corea 22
NO - Norvegia 22
AE - Emirati Arabi Uniti 20
MX - Messico 20
PH - Filippine 19
PE - Perù 17
MA - Marocco 16
ZA - Sudafrica 16
EC - Ecuador 15
TW - Taiwan 15
CL - Cile 14
IQ - Iraq 14
LT - Lituania 14
PT - Portogallo 14
AZ - Azerbaigian 12
BD - Bangladesh 11
IL - Israele 10
UZ - Uzbekistan 10
VE - Venezuela 10
JO - Giordania 9
TH - Thailandia 9
AL - Albania 8
LV - Lettonia 8
NG - Nigeria 8
PA - Panama 8
SA - Arabia Saudita 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BO - Bolivia 7
KZ - Kazakistan 7
RS - Serbia 7
SC - Seychelles 7
AM - Armenia 6
CO - Colombia 6
DZ - Algeria 6
GT - Guatemala 6
NZ - Nuova Zelanda 6
EE - Estonia 5
KG - Kirghizistan 5
LK - Sri Lanka 5
MU - Mauritius 5
PY - Paraguay 5
A1 - Anonimo 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
MK - Macedonia 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
RE - Reunion 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
KE - Kenya 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
MN - Mongolia 3
TN - Tunisia 3
GE - Georgia 2
HN - Honduras 2
IM - Isola di Man 2
LB - Libano 2
Totale 77.400
Città #
Ann Arbor 8.873
Woodbridge 4.514
Fairfield 4.208
Houston 3.479
Singapore 2.833
Chandler 2.779
Dublin 2.603
Wilmington 2.405
Ashburn 2.245
Frankfurt am Main 1.887
Jacksonville 1.834
Hong Kong 1.821
Seattle 1.691
Cambridge 1.456
Milan 1.281
Dearborn 1.261
New York 1.103
Santa Clara 1.087
Princeton 1.001
Nanjing 515
Lawrence 473
Altamura 458
Shanghai 401
Beijing 400
Jakarta 362
Lachine 309
Vienna 284
San Diego 281
Dong Ket 200
Helsinki 187
Rome 169
Andover 166
Boardman 163
Council Bluffs 156
Toronto 156
Lissone 154
Guangzhou 150
Nanchang 147
Brussels 145
Los Angeles 132
London 129
Hebei 128
Nuremberg 127
Chicago 124
Shenyang 120
Changsha 111
Tianjin 102
Monza 95
Ottawa 93
Jinan 91
Fremont 85
Norwalk 85
Falls Church 80
Hangzhou 78
Jiaxing 76
Fuzhou 68
Zhengzhou 61
Huizen 60
Mountain View 59
São Paulo 58
Bergamo 56
Dallas 56
Pune 56
Ningbo 55
Bologna 53
Turin 51
Padova 50
Kocaeli 49
Kunming 49
Florence 48
Munich 47
Redmond 45
Edmonton 43
Hefei 42
Paris 39
Romola 35
San Mateo 35
Taizhou 33
Bari 29
Grafing 29
Cinisello Balsamo 28
University Park 28
Washington 28
Auburn Hills 26
Como 26
Naples 26
Carate Brianza 24
Chengdu 24
Sesto San Giovanni 24
Besana In Brianza 23
Genoa 23
Istanbul 23
Philadelphia 22
Sacramento 22
Lappeenranta 21
Perugia 21
Contursi 20
Mariano Comense 19
Nürnberg 19
Plovdiv 19
Totale 56.965
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 430
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 402
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 360
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 357
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 353
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 346
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 336
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 332
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 327
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 324
Acute myeloid leukaemia niche regulates response to L-asparaginase 323
NIPBL: a new player in myeloid cells differentiation 318
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 314
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 300
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 296
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 291
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 290
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 286
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 282
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 280
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 280
Moral distress in nurses in oncology and haematology units 274
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 271
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 270
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 267
Globalization of pediatric research: Pharmacological RCTs in Latin America 267
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 267
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 265
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 264
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 264
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 260
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 260
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 255
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 254
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 254
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 252
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 252
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 250
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 249
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 249
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 247
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 242
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 240
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 240
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 240
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 239
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 239
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 238
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 237
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 235
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 234
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 234
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 234
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 232
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 231
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 230
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 227
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 225
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 225
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 223
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 222
How I treat infant leukemia 222
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 220
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 219
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 219
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 218
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 215
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 214
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 214
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 213
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 212
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 211
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 211
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 210
A second update on mapping the human genetic architecture of COVID-19 209
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 209
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 209
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 207
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 206
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 206
Early diagnosis of PI3Kδ syndrome in a 2 years old girl with recurrent otitis and enlarged spleen 204
Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells 203
PO-345 Long-Term Survivors of Childhood Acute Lymphoblastic Leukaemia (ALL):Does Parents’Emotional Well-being Affect the Emotional Disposition of Their Survived Children? 203
PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells 202
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 201
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 200
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis 200
Chimeric T-cell receptors: New challenges for targeted immunotherapy in hematologic malignancies 199
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 199
An immune-based biomarker signature is associated with mortality in COVID-19 patients 199
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia 198
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 198
Crescere dopo il tumore: Le emozioni dei bambini guariti da leucemia linfoblastica acuta a confronto con quelle di altre popolazioni 198
Efficient detection of leukemia-related fusion transcripts by multiplex PCR applied on a microelectronic platform 197
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 197
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 196
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 196
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 196
Mapping the human genetic architecture of COVID-19 196
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 194
Totale 24.705
Categoria #
all - tutte 298.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 298.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.839 0 0 0 0 0 0 0 0 0 710 797 332
2020/202111.662 570 770 1.240 1.145 881 1.042 1.094 1.069 908 1.198 721 1.024
2021/20227.459 524 831 947 525 428 513 349 387 565 536 595 1.259
2022/202311.421 1.433 3.399 835 1.009 707 1.699 193 680 746 95 410 215
2023/20248.931 310 290 437 477 1.133 2.263 1.638 318 756 190 282 837
2024/202513.093 1.147 2.329 1.265 1.021 1.852 898 1.486 800 2.269 26 0 0
Totale 80.320